| Literature DB >> 35960516 |
Therese von Hanno1,2, Live Lund Hareide3, Lars Småbrekke4, Bente Morseth5, Monica Sneve6,7, Maja Gran Erke7,8, Ellisiv Bøgeberg Mathiesen2,9, Geir Bertelsen10,11.
Abstract
Purpose: The purpose of this study was to investigate associations between cardiovascular risk factors and the thickness of retinal nerve fiber layer (RNFL), ganglion cell-inner plexiform layer (GCIPL), and outer retina layers (ORL).Entities:
Mesh:
Year: 2022 PMID: 35960516 PMCID: PMC9396695 DOI: 10.1167/iovs.63.9.16
Source DB: PubMed Journal: Invest Ophthalmol Vis Sci ISSN: 0146-0404 Impact factor: 4.925
Figure 1.(A) OCT image of the macula with the elliptic annulus (dimensions of the inner and outer circle: vertical 1 and 4 mm; horizontal 1.2 and 4.8 mm) around the fovea. TS, temporal superior; S, superior; NS, nasal superior; NI, nasal inferior; I, inferior; TI, temporal inferior. (B) Horizontal scan of the macula showing segmentation lines at the outer boundary of retinal nerve fiber layer (RNFL) and the outer boundary of the inner plexiform layer (IPL). The innermost and outermost segmentation lines (not shown) are localized at the level of the internal limiting membrane (ILM) and the retinal pigment epithelium (RPE), respectively. The retina was accordingly segmented in (1) RNFL, (2) ganglion cell-inner plexiform layer (GCIPL) = ganglion cell layer (GCL) + IPL, and (3) outer retinal layers (ORL) = inner nuclear layer (INL) + outer plexiform layer (OPL) + outer nuclear layer (ONL) + photoreceptor inner and outer segments (IS/OS).
Descriptive Characteristics of Participants Included in Cross-Sectional Analysis, Total and by Sex (N = 8288)
| Total | Men | Women | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables |
| Mean/% | SD/(n) | Min | Max |
| Mean/% | SD/(n) | Min | Max |
| Mean/% | SD/(n) | Min | Max | |
| RNFL, µm | 8288 | 32.7 | 3.4 | 12.0 | 52.0 | 3727 | 32.8 | 3.7 | 12.0 | 48.0 | 4561 | 32.7 | 3.3 | 13.0 | 52.0 |
|
| GCIPL, µm | 8288 | 78.0 | 7.1 | 28.0 | 104.0 | 3727 | 77.5 | 7.5 | 28.0 | 104.0 | 4561 | 78.4 | 6.7 | 32.0 | 104.0 |
|
| ORL, µm | 8288 | 128.3 | 8.3 | 90.0 | 196.0 | 3727 | 129.9 | 8.2 | 92.0 | 196.0 | 4561 | 127.0 | 8.2 | 90.0 | 192.0 |
|
| Age, y | 8288 | 61.5 | 9.9 | 38.0 | 87.0 | 3727 | 61.6 | 9.9 | 38.0 | 87.0 | 4561 | 61.4 | 9.9 | 38.0 | 87.0 | 0.357 |
| Sex, male | 8288 | 45.0 | (3727) | |||||||||||||
| Systolic BP, mm Hg | 8266 | 135.1 | 21.7 | 65.0 | 258.0 | 3714 | 136.5 | 19.4 | 83.0 | 221.5 | 4552 | 133.9 | 23.3 | 65.0 | 258.0 |
|
| Daily smoking | 8198 | 3693 | 4505 |
| ||||||||||||
| Never | 37.1 | (3040) | 34.6 | (1279) | 39.1 | (1761) | ||||||||||
| Previous | 47.3 | (3874) | 51.0 | (1884) | 44.2 | (1990) | ||||||||||
| Current | 15.7 | (1284) | 14.4 | (530) | 16.7 | (754) | ||||||||||
| LDL cholesterol, mmol/L | 8227 | 3.7 | 1.0 | 0.8 | 11.4 | 3708 | 3.6 | 1.0 | 0.8 | 11.4 | 4519 | 3.7 | 1.0 | 1.1 | 8.4 |
|
| HDL cholesterol, mmol/L | 8227 | 1.6 | 0.5 | 0.4 | 4.6 | 3708 | 1.4 | 0.4 | 0.4 | 4.6 | 4519 | 1.7 | 0.5 | 0.5 | 4.4 |
|
| HbA1c, % | 8187 | 5.6 | 0.3 | 3.9 | 6.4 | 3689 | 5.61 | 0.3 | 4.3 | 6.4 | 4498 | 5.59 | 0.3 | 3.9 | 6.4 |
|
| Body mass index, kg/m2 | 8278 | 27.0 | 4.2 | 12.0 | 50.6 | 3726 | 27.4 | 3.7 | 17.0 | 50.6 | 4552 | 26.6 | 4.5 | 12.0 | 50.4 |
|
| Weight, kg | 8279 | 77.8 | 14.7 | 33.9 | 150.8 | 3726 | 85.8 | 13.0 | 48.9 | 150.8 | 4553 | 71.2 | 12.6 | 33.9 | 135.7 |
|
| Height, cm | 8279 | 169.5 | 9.2 | 141.7 | 201.2 | 3726 | 176.8 | 6.6 | 147.6 | 201.2 | 4553 | 163.6 | 6.3 | 141.7 | 185.3 |
|
| Total body fat mass, kg | 2842 | 26.3 | 8.4 | 3.3 | 68.3 | 1188 | 24.4 | 7.7 | 6.6 | 52.5 | 1654 | 27.6 | 8.7 | 3.3 | 68.3 |
|
| Total body fat, % | 2842 | 35.2 | 7.9 | 10.3 | 59.6 | 1188 | 29.4 | 5.9 | 11.0 | 45.0 | 1654 | 39.3 | 6.4 | 10.3 | 59.6 |
|
| Refraction (SER), D | 8087 | 0.2 | 2.1 | −13.5 | 10.5 | 3635 | 0.2 | 2.1 | −13.5 | 10.1 | 4452 | 0.2 | 2.2 | −13.2 | 10.5 | 0.947 |
| Drusen, yes | 8288 | 20.5 | (1700) | 3727 | 21.7 | (807) | 4561 | 19.6 | (893) |
| ||||||
N = number of subjects; SD = standard deviation; n = number of cases; Min = minimum; Max = maximum; RNFL = retinal nerve fiber layer; GCIPL = ganglion cell-inner plexiform layer; ORL = outer retinal layers; BP = blood pressure; LDL and HDL = low and high density lipoprotein; HbA1c = glycated hemoglobin; SER = spherical equivalent refraction.
Men: N = 1527 from Tromsø6 and N = 2200 from Tromsø7, and women: N = 1996 with data from Tromsø6 and N = 2565 from Tromsø7. Continuous variables presented as mean and standard deviation (SD), categorical variables (sex, daily smoking, and drusen) as percentages (n) of N. The P value for difference between women and men, continuous variables tested by double sided t-test, and smoking by chi-squared test. The P values < 0.05 are in bold.
Average thickness in 6 sectors of the 14.13 mm2 elliptic annulus centered at the fovea.
Total body fat mass and percent, estimated by dual-energy X-ray absorptiometry: N = 576 from Tromsø6 and N = 2266 from Tromsø7.
Drusen only, no other pathology.
Figure 2.Spherical equivalent refraction and relationship with thickness of the retinal nerve fiber layer (RNFL), ganglion cell-inner plexiform layer (GCIPL), and outer retinal layers (ORLs). Scatterplot and quadratic linear prediction with 95% confidence interval, N = 8087. The relationship with RNFL and GCIPL was curved (quadratic term P = 0.019/<0.001, respectively).
Retinal Layer Thickness and Association With Height, Sex, Age, and Cardiovascular Risk Factors - Cross-Sectional Analyses With Comparisons of Models
| RNFL Thickness (µm) | GCIPL Thickness (µm) | ORL Thickness (µm) | |||||
|---|---|---|---|---|---|---|---|
| Variable | Model | β (95% CI) | β (95% CI) | β (95% CI) | |||
| Height/5 cm | |||||||
| Age + Sex | 0.19 (0.14 to 0.25) |
| 0.11 (−0.01 to 0.23) | 0.066 | 0.34 (0.20 to 0.49) |
| |
| Sex/women | |||||||
| at Age = 50 y | Age + Sex | −0.31 (−0.54 to −0.08) |
| 0.45 (−0.01 to 0.90) | 0.053 | −3.31 (−3.87 to −2.76) |
|
| Age + Sex + Height | 0.19 (−0.09 to 0.47) | 0.182 | 0.74 (0.19 to 1.30) |
| −2.41 (−3.08 to −1.74) |
| |
| Direct effect model | 0.08 (−0.20 to 0.37) | 0.571 | 0.65 (0.10 to 1.21) |
| −2.83 (−3.52 to −2.13) |
| |
| at Age = 65 y | Age + Sex | −0.15 (−0.31 to 0.01) | 0.070 | 0.99 (0.67 to 1.31) |
| −2.71 (−3.09 to −2.32) |
|
| Age + Sex + Height | 0.36 (0.13 to 0.58) |
| 1.29 (0.84 to 1.74) |
| −1.78 (−2.33 to −1.24) |
| |
| Direct effect model | 0.30 (0.08 to 0.53) |
| 1.20 (0.75 to 1.65) |
| −2.09 (−2.65 to −1.52) |
| |
| Age/5 y | |||||||
| Age + Sex | −0.23 (−0.27 to −0.19) |
| −1.07 (−1.14 to −0.99) |
| 0.13 (0.03 to 0.22) |
| |
| Age + Sex + Height | −0.20 (−0.24 to −0.16) |
| −1.04 (−1.12 to −0.97) |
| 0.18 (0.09 to 0.28) |
| |
| Age + Sex + Height + Refraction | −0.08 (−0.12 to −0.04) |
| −1.27 (−1.35 to −1.19) |
| 0.07 (−0.03 to 0.17) | 0.168 | |
| Direct effect model | −0.06 (−0.11 to −0.02) |
| −1.25 (−1.34 to −1.16) |
| 0.08 (−0.03 to 0.19) | 0.149 | |
| Systolic blood pressure/10 mm Hg | |||||||
| Age + Sex | −0.08 (−0.12 to −0.04) |
| −0.13 (−0.21 to −0.06) |
| −0.09 (−0.18 to 0.00) | 0.063 | |
| Age + Sex + Height | −0.07 (−0.11 to −0.03) |
| −0.13 (−0.20 to −0.05) |
| −0.07 (−0.16 to 0.02) | 0.123 | |
| Direct effect model | −0.07 (−0.10 to −0.03) |
| −0.11 (−0.18 to −0.03) |
| −0.05 (−0.14 to 0.04) | 0.297 | |
| Body mass index/5 kg/m2 | |||||||
| Men | Age + Sex | −0.31 (−0.46 to −0.16) |
| −0.52 (−0.81 to −0.22) |
| −0.52 (−0.88 to −0.15) |
|
| Direct effect model | −0.26 (−0.41 to −0.11) |
| −0.61 (−0.91 to −0.31) |
| −0.45 (−0.83 to −0.08) |
| |
| Women | Age + Sex | −0.09 (−0.21 to 0.02) | 0.099 | −0.26 (−0.49 to −0.04) |
| −0.41 (−0.68 to −0.14) |
|
| Direct effect model | −0.10 (−0.21 to 0.02) | 0.110 | −0.25 (−0.48 to −0.03) |
| −0.31 (−0.59 to −0.02) |
| |
| Total body fat/10 %-point | |||||||
| Age + Sex | −0.04 (−0.25 to 0.16) | 0.676 | −0.58 (−0.99 to −0.18) |
| −0.18 (−0.67 to 0.32) | 0.480 | |
| Age + Sex + Height | −0.03 (−0.24 to 0.17) | 0.769 | −0.58 (−0.99 to −0.18) |
| −0.14 (−0.64 to 0.35) | 0.570 | |
| Direct effect model | −0.04 (−0.25 to 0.18) | 0.745 | −0.55 (−0.97 to −0.13) |
| −0.15 (−0.68 to 0.38) | 0.577 | |
| Daily smoking, previous vs. never | Direct effect model | −0.09 (−0.25 to 0.07) | 0.286 | −0.12 (−0.44 to 0.20) | 0.468 | −0.13 (−0.53 to 0.27) | 0.518 |
| Daily smoking, current vs. never | Direct effect model | −0.04 (−0.27 to 0.18) | 0.717 | −0.00 (−0.44 to 0.44) | 0.998 | −1.00 (−1.55 to −0.44) |
|
| LDL cholesterol/1 mmol/L | Direct effect model | 0.07 (−0.01 to 0.15) | 0.079 | 0.13 (−0.02 to 0.29) | 0.089 | −0.08 (−0.27 to 0.11) | 0.408 |
| HDL cholesterol, 1 mmol/L | Direct effect model | −0.04 (−0.22 to 0.14) | 0.662 | −0.18 (−0.53 to 0.18) | 0.328 | 0.47 (0.03 to 0.91) |
|
| HbA1c/1 %-point | Direct effect model | 0.12 (−0.12 to 0.37) | 0.323 | 0.36 (−0.12 to 0.85) | 0.142 | −0.57 (−1.18 to 0.04) | 0.067 |
RNFL = retinal nerve fiber layer; GCIPL = ganglion cell-inner plexiform layer; ORL = outer retinal layers; β = regression coefficient; CI = confidence interval. LDL and HDL = low and high density lipoprotein; HbA1c = glycated hemoglobin.
Analysis for height N = 8279. For the other variables analyses were restricted to the population with complete variables in the direct effect model to allow comparison between models; sex, age, blood pressure, body mass index, daily smoking, LDL, HDL, and HbA1c: N = 7864; total body fat percentage: N = 2734. Direct effect models are given in the legend of Supplementary Figure S2. Age and refraction modeled curvilinear and with interaction term sex-age and sex-body mass index when included as adjustment. Interaction with sex, RNFL/GCIPL/ORL, respectively: height P = 0.34/0.15/0.46; systolic blood pressure P = 0.56/0.34/0.75; body mass index P = 0.08/0.05/0.53; total body fat percent P = 0.98/0.34/0.75. The P values < 0.05 in bold.
Due to the curvilinear relationship with age, results are presented for age 50 and 65 years, obtained by separate analyses with age centered at these age values.
Age modeled linearly, change in thickness by age (mean over the population age-span). Age centered at the population mean (Table 1). Results for GCIPL stratified by sex are reported in the text (Results).
Figure 3.Age and relationship with thickness of the retinal nerve fiber layer (RNFL), ganglion cell-inner plexiform layer (GCIPL), and outer retinal layers (ORL), by sex. Quadratic linear prediction with 95% confidence interval (CI), N = 8288. The relationship was curved (quadratic term P < 0.01 for all 3 layers). Interaction age sex, level of significance: P = 0.10 (RNFL)/0.008 (GCIPL)/0.09 (ORL).
Modifiable Cardiovascular Risk Factors and Association with Change in Retinal Layer Thickness from Tromsø6 (2007 to 2008) to Tromsø7 (2015 to 2016) - Longitudinal Analyses, Direct Effect Models (N = 2460)
| RNFL Thickness (µm) Change Over 8 Y | GCIPL Thickness (µm) Change Over 8 Y | ORL Thickness (µm) Change Over 8 y | ||||
|---|---|---|---|---|---|---|
| Variables | β (95% CI) | β (95% CI) | β (95% CI) | |||
| Systolic BP/10 mm Hg | −0.04 (−0.07 to 0.00) | 0.055 | −0.03 (−0.08 to 0.03) | 0.381 | 0.02 (−0.07 to 0.11) | 0.630 |
| Daily smoking, previous vs. never | −0.17 (−0.33 to −0.01) |
| −0.26 (−0.51 to −0.01) |
| 0.27 (−0.12 to 0.67) | 0.175 |
| Daily smoking, current vs. never | −0.18 (−0.40 to 0.04) | 0.116 | −0.37 (−0.71 to −0.03) |
| 0.38 (−0.16 to 0.92) | 0.167 |
| LDL cholesterol/1 mmol/L | 0.01 (−0.07 to 0.09) | 0.875 | 0.02 (−0.10 to 0.14) | 0.743 | −0.09 (−0.29 to 0.10) | 0.339 |
| HDL cholesterol/1 mmol/L | 0.04 (−0.15 to 0.23) | 0.667 | 0.14 (−0.15 to 0.44) | 0.339 | −0.27 (−0.74 to 0.19) | 0.251 |
| HbA1c/1 %-point | 0.31 (0.08 to 0.54) |
| 0.13 (−0.22 to 0.49) | 0.462 | −0.55 (−1.11 to 0.01) | 0.052 |
| Body mass index/5 kg/m2 | −0.04 (−0.14 to 0.06) | 0.394 | −0.17 (−0.32 to −0.01) |
| −0.11 (−0.36 to 0.13) | 0.358 |
RNFL = retinal nerve fiber layer; GCIPL = ganglion cell-inner plexiform layer; ORL = outer retinal layers; BP = blood pressure; LDL and HDL = low and high density lipoprotein; HbA1c = glycated hemoglobin, β = regression coefficient; CI = confidence interval.
Direct (independent) effect models, according to direct acyclic graphs (DAGs, models specified in the legend of Supplementary Figure S2). No interaction between sex and BMI (P values for interaction, RNFL/GCIPL/ORL respectively = 0.6/0.8/0.3). The P values <0.05 in bold.
Smoking modeled with nearest approximation to direct effect model (axial length was not available). Total effect model β (µm) P values, RNFL/GCIPL/ORL respectively: Smoking, Previous: −0.16 P = 0.045/−0.30, P = 0.017/0.25, P = 0.206. Smoking, current: −0.10 P = 0.354/−0.36 P = 0.031/0.37 P = 0.161.